CAS: 13465-10-6; Indium(I) Chloride

上下游产品

CAS号7440-74-6 铟 | CAS号10025-82-8 氯化铟 | CAS号7782-50-5 氯气

📜盐酸 反应生成氯化亚铟
参考文献:Katai,Akira;Vatanabeh,Xisatsuneh
标题:Katai,Akira;Vatanabeh,Xisatsuneh

专利信息

专利号:WO-2025015696-A1
优先权日:2023-07-17
标题:β-CYC-ASSISTED SYNTHESIS OF IN-V GROUP QUANTUM DOT, AND SYNTHESIS METHOD THEREFOR AND USE THEREOF
发明人：LI GUOQIANG; LIANG JIEHUI; WANG JUNKUN; GUO JIANSEN; LIU PEIXIN
权利人:UNIV SOUTH CHINA TECH
摘要:Provided are β-cyc-assisted synthesis of an In-V group quantum dot, and a synthesis method therefor and the use thereof. The method for β-cyc-assisted synthesis of an In-V group quantum dot comprises: preparing a β-cyc-containing precursor solution of an In source and a V group element source, and subjecting it to a hydrothermal reaction; extracting a stock solution after the hydrothermal reaction by using an organic solvent; removing β-cyc from the stock solution, washing same with water and then extracting same; and heating and concentrating same to obtain a high-concentration In-V group quantum dot solution. With regard to the β-cyc-assisted synthesis of an In-V group quantum dot, the In-V group quantum dot synthesized with the assistance of β-cyc is prepared by using the method for β-cyc-assisted synthesis of an In-V group quantum dot. The use of β-cyc-assisted synthesis of an In-V group quantum dot is the use of the β-cyc-assisted synthesis of an In-V group quantum dot in the field of photovoltaics, and the field of photovoltaics comprises solar cells, photoelectrochemical hydrogen production and photoelectric detectors. Compared with traditional synthesis methods, this synthesis method has the advantages of green and environmentally friendly raw materials, a simple and safe process, a simple and convenient device, efficient and economic synthesis, and being low cost.

专利号:EP-1232226-B1
优先权日:2000-09-08
标题:Synthesis of nanoparticles
发明人：HAUBOLD STEPHAN; HAASE MARKUS; RIWOTZKY CARSTEN; WELLER HORST; MEYSAMMY HEIKE; IBARRA FERNANDO
权利人:NANOSOLUTIONS GMBH
摘要:Production of inorganic nanoparticles that can be fluoresced consisting of a host material containing a dopant comprises using an organic solvent for liquid phase synthesis of the particles.

专利号:US-7955586-B2
优先权日:2007-11-14
标题:Synthesis of I-III-V12 nanoparticles and fabrication of polycrystalline absorber layers
发明人：JUNG DUK-YOUNG; HAN JAE EOK; CHANG JUYEON
权利人:UNIV SUNGKYUNKWAN FOUND
摘要:A method for preparing III-VI 2 nanoparticles and a thin film of polycrystalline light absorber layers. The method for preparing I-III-VI 2 nanoparticles comprises the steps of: (a1) preparing a mixed solution by mixing each element from groups I, III and VI in the periodic table with a solvent; (a2) sonicating the mixed solution; (a3) separating the solvent from the sonicated mixed solution; and (a4) drying the product resulted from the above step (a3) to obtain nanoparticles.

专利号:US-2024215280-A1
优先权日:2022-10-31
标 题:In situ core/shell perovskite nanocrystal material, method of preparation thereof, and light emitting device comprising the same
发明人：LEE TAE-WOO; KIM JOO SUNG
权利人:SEOUL NAT UNIV R&DB FOUNDATION; PEROLED CO LTD
摘要:The present inventive concept relates to an in situ core/shell perovskite nanocrystal film formed by an in situ nanocrystal synthesis process, a method for producing the same, and a light emitting device comprising the same as a light-emitting layer. The in situ core/shell perovskite nanocrystal film formed by the in situ nanocrystal synthesis process according to the present inventive concept exhibits a strong charge confinement effect by nanocrystal formation, and can simultaneously greatly improve the luminescence efficiency and lifetime by maintaining the fast charge transport capability of polycrystalline perovskite.

专利号:CN-116904194-A
优先权日:2023-07-17
标题:A β-cyc-assisted synthesis of In-V family quantum dots and its synthesis method and application

专利号:US-6096874-A
优先权日:1990-10-01
标 题:High affinity tamoxifen derivatives
发明人：WALLACE SIDNEY; YANG DAVID; DELPASSAND EBRAHIM; CHERIF ABDALLAH; QUADRI SYED M
权利人:UNIV TEXAS
摘要:The synthesis of tamoxifen derivatives, most particularly halo, halo alkyl, hydroxy, and amino tamoxifen derivatives is disclosed. The native tamoxifen molecule includes a substituted chemical group positioned on the aliphatic chain of the tamoxifen molecule. Particular tamoxifen derivatives of the invention include chloro, bromo, iodo, fluoro, amino and DTPA tamoxifen derivatives, and corresponding lower alkyl halogenated forms. The halogenated tamoxifen derivatives possess superior binding affinities for estrogen receptor rich tissues, such as uterine tissue and breast tissue, relative to unsubstituted native tamoxifen. Radiolabeled forms of the tamoxifen derivatives may be used as highly specific imaging agents for estrogen receptor rich tissues. The fluoro and bromo tamoxifen derivatives are particularly useful for imaging estrogen receptors by PET whereas the iodinated tamoxifens are particularly useful in imaging estrogen receptors by SPECT. Rapid and efficient methods of preparing the tamoxifen derivatives having high specific activity (>6 Ci/μmol) are also disclosed. Aliphatic chain substituted tamoxifen derivatives are shown to possess greater estrogen receptor binding affinity and more potent tumor cell inhibition than tamoxifen or tamoxifen derivatives substituted at other locations on the molecule (i.e., non-aliphatic chain substituted tamoxifen). The tanioxifen derivatives of the present invention may advantageously be used as anti-cancer therapeutic agents to halt estrogen-receptor positive tumors, such as those of breast and uterine tissue. The present invention also provides a hydrophilic DTPA-tamnoxifen analogue, and uses thereof in imaging estrogen receptor positive ER+ lesions.